1. Home
  2. ELVN

as 10-08-2025 9:38am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Founded: 2016 Country:
United States
United States
Employees: N/A City: BOULDER
Market Cap: 1.2B IPO Year: 2020
Target Price: $41.20 AVG Volume (30 days): 563.5K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.00 EPS Growth: N/A
52 Week Low/High: $13.30 - $30.03 Next Earning Date: 11-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 20.05%

Stock Insider Trading Activity of Enliven Therapeutics Inc. (ELVN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Hohl Benjamin ELVN CHIEF FINANCIAL OFFICER Sep 29 '25 Sell $20.40 3,250 $66,291.23 23,000
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Sep 26 '25 Sell $20.25 4,000 $81,005.20 927,688
Kintz Samuel ELVN PRESIDENT AND CEO Sep 26 '25 Sell $20.06 3,700 $74,227.55 915,392
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Sep 23 '25 Sell $20.03 1,500 $30,045.00 927,688
Kintz Samuel ELVN PRESIDENT AND CEO Sep 23 '25 Sell $20.03 2,800 $56,084.00 915,392
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Sep 19 '25 Sell $19.56 7,000 $135,697.35 927,688
Patel Anish ELVN CHIEF OPERATING OFFICER Sep 8 '25 Sell $20.24 6,667 $134,957.41 283,308
Hohl Benjamin ELVN CHIEF FINANCIAL OFFICER Aug 27 '25 Sell $20.63 3,250 $67,038.73 23,000
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Aug 21 '25 Sell $20.01 7,500 $150,099.00 927,688
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Aug 19 '25 Sell $19.62 5,000 $98,117.50 927,688

Share on Social Networks: